News Focus
News Focus
Followers 7
Posts 674
Boards Moderated 0
Alias Born 08/12/2016

Re: tmac20 post# 231191

Monday, 12/02/2019 5:25:13 PM

Monday, December 02, 2019 5:25:13 PM

Post# of 447752
Tmac’s points & questions

1) Just making a point that sales will need to ramp up if GIA is the strategy.

No kidding. Might as well say they need to keep showing up for work. SMH!

2) I just hope this management is smart enough to recognize a good offer for where they are in the process. 800 sales reps for 1 drug is going to be an expensive rollout.

Disagree. The size of the market that I expect for Vascepa....the cost of 800 reps will be minuscule.

3) Why is it everyone on this board thinks they know everything (i.e. I haven't been in "biz") about everyone else? Where were you a CEO? Did you own the company? Did you sell it? Was it based on a multiple of EBITDA?

Because you say things that someone that knows nothing of business would say. I have owned 4 companies so far. All built by my wife and I. Started with nothing. Have enough that the future of almost 100k shares of amrn are not a huge concern. Its going to be nice but if it went to zero we would still be fine.

It’s not going to zero. It may go to a hundred. After watching some others I won’t be surprised if it does. For certain it’s going to turn a healthy profit in 2020 and if it stays independent it may make quite a bit more $$ than most think.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News